Friends of Cancer Research (Friends) is proud to host our 18th Annual Meeting to address critical issues in the development of new oncology drugs. Friends’ Annual Meeting brings together leaders from federal health and regulatory agencies, academic research, the private sector, and patient advocates to propose unique approaches toward current challenges in drug development.
Click the button above to register.
Session topics will include:
Advancing Seamless Trial Designs from Phase 1 Through Registration in Rare Disease Drug Development
Optimizing Trial Designs for Evaluating Two or More Investigational Agents in a Single Clinical Trial
Ensuring Appropriate Control Regimens in Multi-Regional Clinical Trials